Fatigue is listed as a reported adverse reaction for some GLP-1 receptor agonists, particularly those used at higher doses for weight management such as semaglutide (Wegovy) and liraglutide (Saxenda)
Retatrutide goes further by adding glucagon receptor activation to the mix, creating a synergistic effect that produces greater metabolic changes than either dual or single agonists alone
These include heart medication (digoxin), antifungal medicines, HIV medicines, anti-epileptic medicines (phenytoin), blood thinners (warfarin, clopidogrel), antibiotics such as rifampicin
A., Emslie-Smith, A
Swipe through to discover 6 numbers that can reveal what's really going on beneath the surface
Its effects are subtle but meaningful, particularly when used as part of a larger, personalized protocol